Answers are grounded in this paper and cite their sources.
Endocrinopathic laminitis (or hyperinsulinaemia-associated laminitis) is the most common type of laminitis encountered in equine practice. Strict attention to risk factors and early recognition and diagnosis of insulin dysregulation – as part of equine metabolic syndrome or pituitary pars intermedia dysfunction – greatly decreases the risk of hyperinsulinaemia-associated laminitis. Early treatment and a committed client, veterinary and farriery team is critical to improve the prognosis. Treatment of hyperinsulinaemia-associated laminitis should encompass a three-pronged approach: treat the underlying cause (insulin dysregulation associated with equine metabolic syndrome or pituitary pars intermedia dysfunction); give anti-inflammatories and analgesics; biomechanically support the foot. The field of equine endocrinopathic disease is very active, so it is important to stay up to date on potential diagnostics and therapeutics.
No takes yet. Share an insight, caveat, or question.
Nora S. Grenager (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: